White Papers

  1. Spray Dried Biologics For Injectable Dosage Forms 5/15/2026

    Spray drying enables scalable production of stable, high‑concentration biologics as sterile powders, improving delivery, reducing costs, and overcoming limitations of traditional freeze‑drying methods.

  2. Effect of Shelf Cooling Rate on the Nucleation Temperature of Ice Monitored Using Thermocouples and Wireless Temperature Sensors 5/14/2026

    Freezing conditions shape ice structure, mass transfer resistance, and drying efficiency. Data shows how cooling rate, vial size, and nucleation interact to optimize freeze-drying.

  3. A Practical Guide To Expanding Across Sites While Staying Compliant 5/13/2026

    Standardizing governance and data foundations is critical for scaling multi-site networks without increasing risk. Learn to leverage reusable validation and harmonized workflows for audit readiness.

  4. Accelerating An Innovative High Potency Oncology Therapy To Market 5/13/2026

    Assimilate how disciplined containment, proactive risk management, and collaboration accelerate oncology programs under tight timelines while protecting quality, safety, and global launch readiness.

  5. Email Etiquette That Actually Saves Time for Pharma & Biotech 5/12/2026

    Smarter email habits cut wasted time, reduce inbox noise, and improve collaboration. Clear subject lines, careful recipients, and purposeful tool use keep teams focused on meaningful work.

  6. Accelerating ADC Analytical Method Development Through Platform Innovation 5/11/2026

    Leverage a platform-based analytical development strategy to accelerate ADC IND readiness through early CQA identification, reduced development risk, and streamlined progression from development to patients.

  7. Effective Strategies To Minimize Product Loss During Fill Finish 5/11/2026

    Every drop of high-value biologic lost in fill finish is money left on the table. Learn practical strategies to protect your yield.

  8. The TIDES Manufacturing Mandate: Why Incrementalism Fails And Integration Prevail 5/7/2026

    Manufacturing strategies for peptides and oligonucleotides are being reshaped by scale, complexity, and chronic use. An integrated, end‑to‑end approach shows how early design decisions can prevent costly bottlenecks later.

  9. The Analytical Advantage Across The Development Lifecycle 5/7/2026

    Integrated, regulatory‑ready analytics help accelerate development, strengthen submissions, and ensure consistent product quality throughout the pharmaceutical lifecycle.

  10. Precision By Design: Drug Innovation Through Structure-Based Drug Design (SBDD) 5/6/2026

    Leverage structure-based drug design to gain deeper molecular insights, prioritize high-potential candidates, and accelerate your path from discovery to clinic.